Novartis AG (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 164   

Articles published

NVS 77.09 -0.36 (-0.46%)
price chart
Novartis AG (ADR) (NVS) is Downgraded by Berenberg to Hold
On the company's financial health, Novartis AG (ADR) reported $1.23 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Oct 25, 2016.
Analyst Review Alert on Price Target: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) plunged -1.50% during previous trade, a total of 5.42M shares exchanged hands compared with its average trading volume of 3.39M shares whereas its relative volume is 1.96.
Novartis AG (ADR) (NVS) Q3 Earnings: What Leerink Expects
Novartis AG (ADR) (NYSE:NVS) is expected to report its third quarter financial results on October 25. Leerink Partners analyst Seamus Fernandez expects data to be broadly in line with his estimates and consensus.
Analyst Viewpoints on Price Reaction History: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) soared 0.24% during previous trade, a total of 1.86M shares exchanged hands compared with its average trading volume of 3.16M shares whereas its relative volume is 0.60.
Citi Downgrades Novartis Following SAG Investigation
Citi has downgraded Novartis AG (ADR) (NYSE: NVS) to Neutral from Buy on SAG investigation. Analyst Andrew Baum reported, "The ongoing action of the formidable State Attorney General (SAG) of the Southern District of NY, Preet Bharara, casts a ...
Novartis AG (ADR) (NVS) Under Investigation for 'Sham' Events  Investorplace.com
Xencor Inc (NASDAQ:XNCR) to Collaborate with Pharma Giant Novartis AG (ADR ...
Xencor Inc (NASDAQ:XNCR) shares rose 32.06% to $16.56 on Tuesday after the company officially signed its collaboration agreement with Novartis AG (ADR) (NYSE:NVS), which has agreed to pay $150 million to have access to Xencor's top two product ...
Novartis AG (NVS) Seeks M&A as It Mulls Possible Alcon Sale
Novartis AG (ADR) (NYSE:NVS) is planning to enter into mergers and acquisitions as it continues to weigh options for the long-struggling eye-care business Alcon.
Novartis May Buy Generics Maker Amneal for $8B (NVS)  Investopedia
How Many Heart Failure Deaths Can Novartis AG (ADR) (NYSE:NVS) Entresto Reduce?
A fresh analysis of Novartis AG (ADR) (NYSE:NVS) drug Entresto has shown that it can significantly reduce heart failure deaths.
Novartis AG (NVS) May Fancy AstraZeneca plc (AZN) for Takoever: Reports
The American depository receipts of AstraZeneca plc (ADR) (NYSE:AZN) traded up over 1% on the New York exchange Friday, after a report suggested that the company may attract a takeover interest from Novartis AG (ADR) (NYSE:NVS). Novartis' ADRs ...
Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well ...
The injectable treatment option later expanded to Novartis AG (ADR) (NYSE: NVS)'s Extavia, Biogen's Plegridy and Glatopa, the generic version of Copaxone developed by Novartis' Sandoz unit.